Evolution Wealth Management’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13K Buy
+491
New +$12.8K 0.01% 488

Other funds holding ARQT

Evolution Wealth Management's ARQT Position: Q3 2026 in Review

Evolution Wealth Management opened a new position in Arcutis Biotherapeutics (ARQT) in Q3 2026: 491 shares worth $13K. The stake represents 0.01% of the portfolio and ranks #488 among its holdings.

294 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.

  • Evolution Wealth Management held 491 shares of Arcutis Biotherapeutics worth $13K as of Q3 2026.
  • Arcutis Biotherapeutics was a new Evolution Wealth Management position in Q3 2026.
  • Arcutis Biotherapeutics made up 0.01% of Evolution Wealth Management's portfolio in Q3 2026, its #488 holding.
  • 294 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.

Based on Evolution Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.